Related Experiment Videos
Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis.
1Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Summary
This study developed a method to select tissue-specific cDNA clones using expressed sequence tag (EST) databases. This approach successfully identified neural crest-derived genes for microarray analysis, revealing differential gene expression in melanoma.
Area of Science:
- Genomics and Bioinformatics
- Molecular Biology
- Developmental Biology
Background:
- Simultaneous gene expression comparison is possible using cDNA microarrays.
- Selecting tissue-appropriate cDNA sets enhances the discovery of altered gene expression.
- The expressed sequence tag (EST) database offers extensive sequence information.
Purpose of the Study:
- To leverage the dbEST database for identifying a neural crest-derived melanocyte cDNA set for microarray analysis.
- To develop and validate an approach for selecting tissue-appropriate cDNAs for gene expression studies.
Main Methods:
- Utilized dbEST to identify a cDNA library (library 198) enriched for neural crest-expressed genes.
- Selected 852 clustered ESTs from library 198 based on their tissue distribution profile.
- Performed microarray analysis comparing the Mel1 array (neural crest-selected) against a non-biased array.
Main Results:
- Library 198 showed a significant bias towards neural crest-expressed genes compared to ubiquitously expressed control genes.
- The Mel1 array (852 ESTs) revealed significant differential gene expression in melanoma cell lines versus kidney epithelial cells (P < 1 x 10(-8)).
- A control array of 1,238 ESTs selected without library bias did not show significant differential expression (P = 0.204).
Conclusions:
- The study presents a validated approach for selecting tissue-specific cDNAs using EST database information.
- This method enables the examination of gene expression profiles relevant to developmental processes and diseases, such as melanoma.
- Tissue-appropriate cDNA selection significantly improves the ability to detect biologically relevant gene expression changes.